Dudediligence.

Processa Pharmaceuticals, Inc

PCSANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$3.4MSep ’24−$2.7MDec ’24−$2.8MMar ’25−$3.9MJun ’25−$3.4MSep ’25$23.8MDec ’25−$3.4MMar ’26−$3.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$0.00$0.00none on filenone on filenone on file
Operating income−$12.1M−$27.5M−$11.5M−$12.1M−$14.0M
Net income−$11.4M−$27.4M−$11.1M−$11.9M$13.6M
Operating cash flow−$8.7M−$9.6M−$8.1M−$11.2M−$11.4M
Free cash flownone on filenone on file−$8.1M−$11.2Mnone on file
Cash$16.5M$6.5M$4.7M$1.2M$5.5M
Shares outstanding15.7M801.8K1.3M148.1K2.6M